GSK 597901
Alternative Names: GSK597901Latest Information Update: 01 Aug 2023
At a glance
- Originator GlaxoSmithKline
- Class Antiasthmatics
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 05 Dec 2003 Phase-II clinical trials in Chronic obstructive pulmonary disease (unspecified route)
- 05 Dec 2003 Phase-II clinical trials in Asthma (unspecified route)
- 08 Jul 2003 Phase-I clinical trials in Chronic obstructive pulmonary disease (unspecified route)